CARDLYTICS INC - NOTE 1.000% 9/1

CUSIP: 14161WAB1

Q2 2024 13F Holders as of 30 Jun 2024

Type / Class
Debt / NOTE 1.000% 9/1
Market price (% of par)
92.24%
Total 13F principal
$19,428,370
Principal change
-$5,778,750
Total reported market value
$42,083,642
Number of holders
11
Value change
+$2,006,360
Number of buys
4
Number of sells
3

Quarterly Holders Quick Answers

What is CUSIP 14161WAB1?
CUSIP 14161WAB1 identifies 14161WAB1 - CARDLYTICS INC - NOTE 1.000% 9/1 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CARDLYTICS INC - NOTE 1.000% 9/1 as of Q2 2024

As of 30 Jun 2024, CARDLYTICS INC - NOTE 1.000% 9/1 was held by 11 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $19,428,370 in principal (par value) of the bond. The largest 10 bondholders included PenderFund Capital Management Ltd., Linden Advisors LP, OAKTREE CAPITAL MANAGEMENT LP, WHITEBOX ADVISORS LLC, WELLINGTON MANAGEMENT GROUP LLP, Russell Investments Group, Ltd., 683 Capital Management, LLC, Penn Mutual Asset Management, Context Capital Management, LLC, and Chicago Capital Management, LLC. This page lists 11 institutional bondholders reporting positions for the Q2 2024 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.